The Hong Kong University of Science and Technology

HKUST and SIIC Launch HK$600 Million Biotechnology Fund to Accelerate Healthcare Innovation

- The Hong Kong University of Science and Technology (HKUST) has partnered with Shanghai Industrial Investment Holdings (SIIC) to establish the HK$600 million Hong Kong Biotechnology Fund (HKBF) targeting biotech and life science investments. - Half of the fund will be dedicated to HKUST-associated ventures, supporting startups founded by university members and projects utilizing HKUST technologies across sectors including neurodegeneration, ophthalmic drug delivery, and gene therapy. - The HKBF represents the first venture investment under HKUST's HK$500 million Redbird Innovation Fund and aligns with the Hong Kong government's vision to establish the city as an international health and medical innovation hub.